March 27 (Reuters) - ADC Therapeutics SA ADCT.N:
ADC THERAPEUTICS Q4 NET INCOME USD -30.727 MILLION
ADC THERAPEUTICS Q4 OPERATING EXPENSES USD -49.346 MILLION
ADC THERAPEUTICS Q4 BASIC EPS USD -0.29
ADC THERAPEUTICS Q4 INCOME FROM OPERATIONS USD -32.436 MILLION
$250.9M IN CASH AS OF DECEMBER 31, 2024, PROVIDES RUNWAY EXPECTED TO FUND OPERATIONS INTO SECOND HALF OF 2026
Source text: ID:nPn37Y0xza
Further company coverage: ADCT.N
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.